英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
(S)-2-((R)-1-(3,5-bis(trifluoroMethyl)phenyl)ethoxy)-4-benzylMorpholin-3-one |
(2S)-2-[(1R)-1-[3,5-二(三氟甲基)苯基]乙氧基]-4-芐基-3-嗎啉酮 |
327623-36-9 |
詳細(xì)
|
Fulvestrant 9-Sulfone |
氟維司群-9-砜;氟維司群EP雜質(zhì)B |
98008-06-1 |
詳細(xì)
|
6-Keto Fulvestrant; Fulvestrant EP Impurity F |
氟維司群雜質(zhì)F |
|
詳細(xì)
|
Fulvestrant Sterol DiMer |
氟維司群甾醇二聚物;氟維司群雜質(zhì)D |
|
詳細(xì)
|
7β-Fulvestrant |
7β-氟維司群 ;氟維司群EP雜質(zhì)A |
407577-53-1 |
詳細(xì)
|
Eplerenone EP Impurity B |
依普利酮EP雜質(zhì)B |
192704-82-8 |
詳細(xì)
|
11-a-Hydroxy canrenone methyl ester |
11A-羥基坎利酮丙烯酸甲酯 |
192704-56-6 |
詳細(xì)
|
3-oxo-17α-pregn-4-ene-7α,9:21,17-dicarbolactone |
依普利酮雜質(zhì)-7,9-內(nèi)酯 |
|
詳細(xì)
|
Calcium Levofolinate EP Impurity I |
左亞葉酸鈣EP雜質(zhì)I |
31690-11-6 |
詳細(xì)
|
Folic Acid EP Impurity E |
葉酸EP雜質(zhì)E |
1391068-26-0 |
詳細(xì)
|
Folinic Acid EP Impurity E |
左亞葉酸鈣EP雜質(zhì)E |
944737-05-7 |
詳細(xì)
|
Sugammadex sodium |
舒更葡糖鈉 |
343306-79-6 |
詳細(xì)
|
(3,5-di-benzyloxy)benzoic acid benzyl ester |
特布他林雜質(zhì)3 |
50513-72-9 |
詳細(xì)
|
2-(tert-butylamino)-1-(3,5-dihydroxyphenyl)ethanone |
特布他林EP雜質(zhì)C |
139508-58-0 |
詳細(xì)
|
2-(3,5-dihydroxyphenyl)-2-hydroxyacetic acid |
特布他林雜質(zhì)9 |
52238-36-5 |
詳細(xì)
|
3-quinolinecarboxylic acid, 1-(6-amino-3,5-difluoro-2-pyridinyl)-7-[3-[3-[[1-(6-amino-3,5-difluoro-2-pyridinyl)-3-carboxy-8-chloro-6-fluoro-1,4-dihydro-4-oxo-7-quinolinyl]amino]-2-hydroxypropoxy]-1-azetidinyl]-8- |
德拉沙星二聚體雜質(zhì) |
1093185-35-3 |
詳細(xì)
|
Fluticasone EP IMpurity B |
氟替卡松雜質(zhì)B |
948566-12-9 |
詳細(xì)
|
(3alpha,14beta,16alpha)-14,15-dihydro-14-hydroxyeburnamenine-14-carboxylic acid |
長(zhǎng)春酸胺 |
28152-73-0 |
詳細(xì)
|
folic Acid impurity H |
葉酸雜質(zhì)H |
|
詳細(xì)
|
3-hydroxy-5-benzyloxybenzoic acid |
3-(芐氧基)-5-羥基苯甲酸 |
159506-17-9 |
詳細(xì)
|
1-(3-(benzyloxy)-5-hydroxyphenyl)ethanone |
3-羥基-5-芐氧基苯乙酮 |
81732-54-9 |
詳細(xì)
|
3,5-dibenzyloxybenzoic acid |
3,5-二芐氧基苯甲酸 |
28917-43-3 |
詳細(xì)
|
methyl 3,5-bis(benzyloxy)benzoate |
3,5-二芐氧基苯甲酸甲酯 |
58605-10-0 |
詳細(xì)
|
1-carbomethoxy-3,5-dihydroxybenzene |
3,5-二羥基苯甲酸甲酯 |
2150-44-9 |
詳細(xì)
|
3,5-Dihydroxybenzoic acid |
3,5-二羥基苯甲酸 |
99-10-5 |
詳細(xì)
|
1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-((3-chloro-2-hydroxypropyl)amino)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; delafloxacin impurity |
德拉沙星雜質(zhì)1 |
|
詳細(xì)
|
1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-3-hydroxy-7-(3-hydroxyazetidin-1-yl)-4(1H)-quinolinone; delafloxacin impurity |
德拉沙星雜質(zhì)2 |
|
詳細(xì)
|
1-(6-amino-3,5-difluoropyridin-2-yl)-6,8-difluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; delafloxacin impurity |
德拉沙星雜質(zhì)3 |
2097714-12-8 |
詳細(xì)
|
FLUTICASONE PROPIONATE, 17-BETA CARBOXYLIC ACID |
6Α,9Α-二氟-11Β-羥基-16Α-甲基-3-氧代-17Α-(丙酰氧基)雄甾-1,4-二烯-17 Β-羧酸 |
65429-42-7 |
詳細(xì)
|
(7a,17a)-17-Hydroxy-3-oxo-pregna-4,9(11)-diene-7,21-dicarboxylicacid g-lactone methyl ester |
(7a,17a)-17-羥基-3-氧代-孕甾-4,9(11)-二烯-7,21-二羧酸 gamma-內(nèi)酯甲酯 |
95716-70-4 |
詳細(xì)
|
7-methyl hydrogen 17α-hydroxy-3-oxopregna-4,11-diene-7α,21-dicarboxylate, γ-lactone |
依普利酮雜質(zhì)7 |
192704-70-4 |
詳細(xì)
|
(7β,11α,17α)-9,11-Epoxy-17-hydroxy-3-oxo-pregn-4-ene-7,21-dicarboxylic Acid γ-Lactone Methyl Ester |
7β-依普利酮 |
209253-81-6 |
詳細(xì)
|
Fulvestrant Extended |
氟維司群雜質(zhì)C |
|
詳細(xì)
|
Folic Acid EP Impurity C |
葉酸EP雜質(zhì)C |
47707-78-8 |
詳細(xì)
|
11-Oxo Fluticasone Propionate |
氟替卡松雜質(zhì)F |
1219174-94-3 |
詳細(xì)
|
Fluticasone Dimer Impurity |
氟替卡松二聚物雜質(zhì) |
220589-37-7 |
詳細(xì)
|
Ticabesone Propionate |
氟替卡松雜質(zhì)D |
73205-13-7 |
詳細(xì)
|
Fluticasone Acetate |
乙酰化氟替卡松 |
80474-24-4 |
詳細(xì)
|
(6a,11b,16a,17a)-6,9-Difluoro-11,17-dihydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carboxylic acid |
氟米松酸 |
28416-82-2 |
詳細(xì)
|
(6α,11β,16α,17α)-6,9-Difluoro-11-hydroxy-16-Methyl-spiro[androsta-1,4-diene-17,5'-[1,3]oxathiolane]-2',3,4'-trione |
氟替卡松相關(guān)物質(zhì)B |
219719-95-6 |
詳細(xì)
|
Fluticasone propionate |
氟替卡松丙酸酯 |
80474-14-2 |
詳細(xì)
|
1,2-Dihydro Fluticasone Propionate |
氟替卡松雜質(zhì)E |
105613-90-9 |
詳細(xì)
|
DesfluoroMethyl Fluticasone Propionate Disulfide |
去氟甲基丙酸氟替卡松二硫化物 |
201812-64-8 |
詳細(xì)
|
Albuterol Methyl Ether |
沙丁胺醇EP雜質(zhì)A |
870076-72-5 |
詳細(xì)
|
t-Butylnorsynephrine |
沙丁胺醇EP雜質(zhì)B |
96948-64-0 |
詳細(xì)
|
Levalbuterol Related Compound B (20 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-methyl-benzenemethanol) |
沙丁胺醇EP雜質(zhì)C |
18910-68-4 |
詳細(xì)
|
Albuterol Aldehyde |
沙丁胺醇EP雜質(zhì)D |
156339-88-7 |
詳細(xì)
|
Albuterol diMer |
沙丁胺醇EP雜質(zhì)F |
147663-30-7 |
詳細(xì)
|
alpha-[(benzyl-tert-butylamino)methyl]-m-xylene-4,alpha,alpha'-triol |
4-(2-(芐基(叔丁基)氨基)-1-羥基乙基)-2-(羥甲基)苯酚 |
24085-03-8 |
詳細(xì)
|
2-[(1,1-DIMETHYLETHYL)(PHENYLMETHYL)AMINO]-1-[4-HYDROXY-3-(HYDROXY-METHYL)PHENYL]ETHANONESALBUTAMOL |
沙丁胺醇EP雜質(zhì)G |
64092-10-0 |
詳細(xì)
|
Maropitant Citrate |
馬羅皮坦檸檬酸鹽 |
359875-09-5 |
詳細(xì)
|
Paricalcitol |
帕立骨化醇 |
131918-61-1 |
詳細(xì)
|
SalbutaMon Hydrochloride |
沙丁胺醇EP雜質(zhì)J |
41489-89-8 |
詳細(xì)
|
SalbutaMol IMpurity K |
沙丁胺醇EP雜質(zhì)K |
898542-80-8 |
詳細(xì)
|
Levalbuterol Related Compound C (30 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-(methoxymethyl)-benzenemethanol) |
沙丁胺醇EP雜質(zhì)M |
18910-70-8 |
詳細(xì)
|
Levalbuterol Related Compound E HCl |
沙丁胺醇EP雜質(zhì)E |
69716-64-9 |
詳細(xì)
|
SalbutaMol DiMer |
沙丁胺醇EP雜質(zhì)N |
149222-15-1 |
詳細(xì)
|
4-tert-ButylaMinoethyl-2-Methylphenol |
沙丁胺醇EP雜質(zhì)H |
132183-64-3 |
詳細(xì)
|
4-Benzyl Albuterol |
沙丁胺醇EP雜質(zhì)I |
56796-66-8 |
詳細(xì)
|
(2S)-2-[[4-[(2-fluorophenyl)methoxy]phenyl]methylamino]propanamide |
(S)-2-[[4-[(2-氟芐基)氧基]芐基]氨基]丙酰胺 |
133865-88-0 |
詳細(xì)
|
(R)-5-(chloromethyl)-3-(3-fluoro-4-(6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl)phenyl)oxazolidin-2-one |
特地唑胺雜質(zhì) |
1239662-46-4 |
詳細(xì)
|
Regorafenib |
瑞格非尼 |
755037-03-7 |
詳細(xì)
|
Canrenone |
坎利酮 |
976-71-6 |
詳細(xì)
|
macitentan |
馬西替坦 |
441798-33-0 |
詳細(xì)
|
Salbutamol Impurity 6 |
沙丁胺醇雜質(zhì)6 |
870076-73-6 |
詳細(xì)
|
4-HYDROXY-3-(HYDROXYMETHYL)BENZALDEHYDE |
4-羥基-3-羥基甲基苯甲醛 |
54030-32-9 |
詳細(xì)
|
5-Bromoacetyl-2-hydroxybenzaldehyde |
5-溴乙?;?2-羥基苯甲醛 |
115787-50-3 |
詳細(xì)
|
5-O-DESMETHYL OMEPRAZOLE |
5-O-去甲基奧美拉唑 |
151602-49-2 |
詳細(xì)
|
(R)-Omeprazole Sodium Salt |
(R)-奧美拉唑鈉鹽 |
161796-77-6 |
詳細(xì)
|
3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one |
5,6-二氫-3-(4-嗎啉基)-1-[4-(2-氧代-1-哌啶基)苯基]-2(1H)-吡啶酮 |
545445-44-1 |
詳細(xì)
|
2-(((3ar,4s,6r,6as)-6-aminotetrahydro-2,2-dimethyl-4h-cyclopenta-1,3-dioxol-4-yl)oxy)-ethanol (2r,3r)-2,3-dihydroxybutanedioate |
2-[[(3AR,4S,6R,6AS)-6-氨基四氫-2,2-二甲基-4H-環(huán)戊并-1,3-二惡茂 -4-基]氧基]-乙醇 (2R,3R)-2,3-二羥基丁二酸鹽 |
376608-65-0 |
詳細(xì)
|
(1S,3S,5S)-3-(Aminocarbonyl)-2-azabicyclo[3.1.0]hexane-2-carboxylic acid tert-butyl ester |
(1S,3S,5S)-3-(氨基羰基)-2-氮雜雙環(huán)[3.1.0]己烷-2-甲酸叔丁酯 |
361440-67-7 |
詳細(xì)
|
Boc-3-Hydroxy-1-adamantyl-D-glycine |
N-叔丁氧羰基-3-羥基-1-金剛烷基-D-甘氨酸 |
361442-00-4 |
詳細(xì)
|
16α-Butyloxyprednisolone (Budenoside IMpurity) |
布地奈德雜質(zhì)I |
113930-13-5 |
詳細(xì)
|
21-Acetoxy-11β-hydroxy-16α,17α-propylmethylenedioxpregna-1,4-diene-3,20-dione |
布地奈德雜質(zhì)K |
51333-05-2 |
詳細(xì)
|
(16α)-16,17-[Butylidenebis(oxy)]-21-hydroxypregna-1,4-diene-3,11,20-trione |
布地奈德雜質(zhì)L |
216453-74-6 |
詳細(xì)
|
Dexmedetomidine hydrochloride |
鹽酸右美托咪定 |
145108-58-3 |
詳細(xì)
|
Di-Norbudesonide (Mixture of DiastereoMers) |
布地奈德雜質(zhì)B |
1040085-98-0 |
詳細(xì)
|
Eplerenone |
依普利酮 |
107724-20-9 |
詳細(xì)
|
N-Methyl OMeprazole (Mixture of isoMers with the Methylated nitrogens of iMidazole) |
埃索美拉唑雜質(zhì)H193/61 |
89352-76-1 |
詳細(xì)
|
2-Keto ZolpideM |
唑吡坦雜質(zhì) |
400038-68-8 |
詳細(xì)
|
(S)-Tedizolid |
特地唑胺雜質(zhì) A |
1431699-67-0 |
詳細(xì)
|
1-(4-Methoxyphenyl)-2-aminoethyl cyclohexanol hydrochloride |
1-[2-氨基-1-(4-甲氧基苯基)乙基]環(huán)己醇鹽酸鹽 |
93413-77-5 |
詳細(xì)
|
1,2-BenzenedicarboxaMide, N1,N2-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- |
利伐沙班雜質(zhì) |
1365267-36-2 |
詳細(xì)
|
1H-ISOINDOLE-1,3(2H)-DIONE, 2-[[(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-5-OXAZOLIDINYL]METHYL]- |
2-[[(5S)-2-氧代-3-[4-(3-氧代-4-嗎啉基)苯基]-5-噁唑烷基]甲基]-1H-異吲哚-1,3(2H)-二酮 |
446292-08-6 |
詳細(xì)
|
2-[[2-2(2-Amino-4-thiazolyl)acetyl]amino]-4-thiazoleacetic Acid |
2-(2-(2-(2-氨基噻唑-4-基)乙酰氨基)噻唑-4-基)乙酸 |
2036283-13-1 |
詳細(xì)
|
2-Amino-4-methoxy-5-(3-morpholinopropoxy)benzonitrile |
2-氨基-4-甲氧基-5-(3-嗎啉丙氧基)苯甲腈 |
675126-26-8 |
詳細(xì)
|
2-Amino-4-Methoxy-5-(3-Morpholinopropoxy)benzonitrile |
2-氨基-4-甲氧基-5-(3-嗎啉丙氧基)苯腈 |
675126-27-9 |
詳細(xì)
|
5-chloro-N-(4-((S)-5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)-N-(2-(2-oxo-2-((((S)-2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)amino)ethoxy)ethyl)thiophene-2-carboxamide |
利伐沙班雜質(zhì)I |
1632463-24-1 |
詳細(xì)
|
5-R-Rivaroxaban |
5-R-利伐沙班 |
865479-71-6 |
詳細(xì)
|
6,6'-bis(2-methyl-2H-tetrazol-5-yl)-3,3'-bipyridine |
特地唑胺雜質(zhì)41 |
2095840-91-6 |
詳細(xì)
|
9-(2'-ACETOXYETHOXYMETHYL)-GUANINE |
醋酸阿昔洛韋 |
102728-64-3 |
詳細(xì)
|
AcetaMide, N-[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- |
利伐沙班雜質(zhì) |
1429334-00-8 |
詳細(xì)
|
Bendamustine Impurity D |
苯達(dá)莫司汀雜質(zhì)A |
191939-34-1 |
詳細(xì)
|
BOC-(R)-3-AMINO-4-(3,4-DIFLUORO-PHENYL)-BUTYRIC ACID |
BOC-(R)-3-氨基-4-(3,4-二氟苯基)丁酸 |
269396-59-0 |
詳細(xì)
|
BOC-(R)-3-AMINO-4-(3,4-DIFLUORO-PHENYL)-BUTYRIC ACID |
BOC-(R)-3-氨基-4-(3,4-二氟苯基)丁酸 |
486549-98-7 |
詳細(xì)
|
2-ThiophenecarboxaMide, N-[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]- |
利伐沙班雜質(zhì)A |
1415566-28-7 |
詳細(xì)
|
5-(4-methoxyphenyl)-3-methyl-1-oxa-3-azaspiro[5.5]undecane |
5-(4-甲氧基苯基)-3-甲基-1-氧-3-氮雜并[5.5]十一烷 |
93413-70-8 |
詳細(xì)
|
D,L N-Desmethylvenlafaxine |
去甲文拉法辛雜質(zhì) |
149289-30-5 |
詳細(xì)
|
21-Dehydro Budesonide |
布地奈德雜質(zhì)D |
85234-63-5 |
詳細(xì)
|